NCT06184594
Evaluating the Efficacy of the eNav Toolkit to Improve Colorectal Cancer Screening
Enrolling by Invitation
NAAges 45–75InterventionalIcahn School of Medicine at Mount SinaiInvestigator-initiated
~400 participants
Updated 2026-02-17 on ClinicalTrials.gov
What's tested:eNavStandard of Care
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Colorectal Cancer (CRC) Screening completion
Measured over End of study, at 6 months
Conditions
Where it's being run
1 sites across 1 statesNew York1
Study leadership
- Sarah Miller, PsyD · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patient treated at the Institute for Family Health (IFH)
Patient 45 to 75 years old
English or Spanish speaking
Able to provide consent within the study time frame (within a month of the primary care appointment
Patients have access to a computer, tablet or mobile device to access the eNav Toolkit OR willing to use a clinic provided device, in person at either IFH OR Mount Sinai
Patient scheduled for a primary care appointment at IFH
Patients are due for colorectal cancer screening (as determined by the health maintenance alert in the medical chart)
Exclusion
Unable to provide informed consent
What this trial measures
- Colorectal Cancer (CRC) Screening completionEnd of study, at 6 months
CRC, Yes/No Medical chart review will determine whether the CRC screening was complete. If a patient does not have a CRC screening result recorded in their medical record, the research team will call the patient to inquire whether they have completed the CRC screening.